AbbVie (ABBV) Earnings Date, Estimates & Call Transcripts $198.10 -0.76 (-0.38%) Closing price 03:59 PM EasternExtended Trading$198.26 +0.16 (+0.08%) As of 07:56 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock AbbVie Earnings Summary AbbVie released Q2 2025 earnings on July 31, 2025, reporting an EPS of $2.97, which missed the consensus estimate of $3.24 by $0.27. Quarterly revenue rose 6.6% year-over-year to $15.42 billion, above the consensus estimate of $14.93 billion. With a trailing EPS of $2.10 and a P/E Ratio of 94.33, AbbVie's earnings are expected to grow 13.57% next year, from $12.31 to $13.98 per share. Latest Q2 Earnings DateJul. 31EstimatedConsensus EPS (Jul. 31) $3.24 Actual EPS (Jul. 31) $2.97 Missed By -$0.27 Actual Revenue (Jul. 31) $15.42BQ2 2025 Earnings ResourcesQ2 2025 Earnings ReportConference Call Transcript & Audio Press Release (8-K) Quarterly Report (10-Q)SEC FilingPowered by Get AbbVie Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on AbbVie and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataABBV Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.ABBV Estimated and Actual Revenue by QuarterEstimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. AbbVie Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateRevenue EstimateCompany EPS GuidanceCompany Revenue GuidanceQ1 20253$2.37$2.42$2.392.340 - 2.380 - Q2 20253$2.87$2.88$2.872.840 - 2.880 - Q3 20253$3.02$3.34$3.19Q4 20253$3.27$3.39$3.31 FY 2025 12 $11.53 $12.03 $11.76 Q1 20262$2.88$3.11$3.00Q2 20262$3.33$3.93$3.63Q3 20262$3.63$3.74$3.69Q4 20262$3.75$3.80$3.78 AbbVie Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame Start Date End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails7/31/2025Q2 2025$3.24$2.97 -$0.27$0.52$14.93B$15.42B4/25/2025Q1 2025$2.40$2.46+$0.06$0.72$12.91B$13.34B1/31/2025Q4 2024$2.98$2.16 -$0.82-$0.02$14.81B-10/30/2024Q3 2024$2.92$3.00+$0.08$5.12$14.28B$14.46B7/25/2024Q2 2024$2.57$2.65+$0.08$4.53$14.02B$14.46B5/3/2024Q1 2024$2.26$2.31+$0.05$3.85$11.93B$12.31B2/2/2024Q4 2023$2.76$2.79+$0.03$5.12$14.02B$14.30B10/27/2023Q3 2023$2.86$2.95+$0.09$4.90$13.72B$13.93B AbbVie Earnings - Frequently Asked Questions When did AbbVie announce their last quarterly earnings? AbbVie (NYSE:ABBV) last announced its quarterly earning data on Thursday, July 31, 2025. Learn more on ABBV's earnings history. What guidance has AbbVie issued on next quarter's earnings? AbbVie issued an update on its FY 2025 earnings guidance on Monday, July, 7th. The company provided earnings per share (EPS) guidance of 11.670-11.870 for the period. The company issued revenue guidance of -. Did AbbVie beat their earnings estimates last quarter? In the previous quarter, AbbVie (NYSE:ABBV) missed the analysts' consensus estimate of $3.24 by $0.27 with a reported earnings per share (EPS) of $2.97. Learn more on analysts' earnings estimate vs. ABBV's actual earnings. How can I listen to AbbVie's earnings conference call? The conference call for AbbVie's latest earnings report can be listened to online. Listen to Conference Call How can I read AbbVie's conference call transcript? The conference call transcript for AbbVie's latest earnings report can be read online. Read Transcript How can I view AbbVie's earnings report? AbbVie's earnings report can be found in their filing with the SEC. View SEC filing How much revenue does AbbVie generate each year? AbbVie (NYSE:ABBV) has a recorded annual revenue of $56.33 billion. How much profit does AbbVie generate each year? AbbVie (NYSE:ABBV) has a recorded net income of $4.28 billion. ABBV has generated $2.10 earnings per share over the last four quarters. What is AbbVie's price-to-earnings ratio? AbbVie (NYSE:ABBV) has a trailing price-to-earnings ratio of 94.33 and a forward price-to-earnings ratio of 16.09. The price/earnings-to-growth ratio is 1.28. What is AbbVie's EPS forecast for next year? AbbVie's earnings are expected to grow from $12.31 per share to $13.98 per share in the next year, which is a 13.57% increase. More Earnings Resources from MarketBeat Related Companies Amgen Earnings Results Gilead Sciences Earnings Results Moderna Earnings Results Abbott Laboratories Earnings Results Bristol Myers Squibb Earnings Results Johnson & Johnson Earnings Results Eli Lilly and Company Earnings Results Merck & Co., Inc. Earnings Results Pfizer Earnings Results Zoetis Earnings Results Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Airbnb Beats Earnings, But the Growth Story Is Losing AltitudeDutch Bros Just Flipped the Script With a Massive Earnings BeatIs Eli Lilly’s 14% Post-Earnings Slide a Buy-the-Dip Opportunity?Constellation Energy’s Earnings Beat Signals a New EraRealty Income Rallies Post-Earnings Miss—Here’s What Drove ItDon't Mix the Signal for Noise in Super Micro Computer's EarningsWhy Monolithic Power's Earnings and Guidance Ignited a Rally This page (NYSE:ABBV) was last updated on 8/8/2025 by MarketBeat.com Staff From Our PartnersHIDDEN IN THE BOOK OF GENESIS…“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredAmazon’s big Bitcoin embarrassmentBitcoin just passed Amazon in total market cap — but most investors are missing the bigger opportunity. Whi...Brownstone Research | SponsoredBREAKING: The House just passed 3 pro-crypto bills!THREE pro-crypto bills just passed the House! Now, experts believe altcoin season is officially here. Crypto 101 Media | SponsoredFormer CIA Officer Reveals How Gold Saved His Life This isn’t just another gold investing book—it’s a survival playbook written by a former CIA officer trained...Advantage Gold | SponsoredGreen Light for These StocksGuess Who Washington Will Partner With Next? The U.S. government just made a bold $400 million move... beco...Stansberry Research | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredHow high will gold surge?Weiss Gold Veteran Makes Shocking New Call Weiss expert Sean Brodrick went out on a limb last year and decl...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding AbbVie Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share AbbVie With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
